Chemoprevention for malaria with monthly intermittent preventive treatment with dihydroartemisinin-piperaquine in pregnant women living with HIV on daily co-trimoxazole in Kenya and Malawi: a randomised, double-blind, placebo-controlled trial.
肯亞和馬拉維對於HIV陽性懷孕婦女進行每月二甲基青蒿素-哌喹治療的間歇性預防治療,以及在日常服用聯苯甲唑的疟疾化學預防:一項隨機、雙盲、安慰劑對照試驗。
Lancet 2024-03-13
Efficacy of typhoid conjugate vaccine: final analysis of a 4-year, phase 3, randomised controlled trial in Malawian children.
輝瑞公司新冠疫苗的有效性:在馬拉威兒童中進行的為期4年的第3期隨機對照試驗的最終分析。
Lancet 2024-02-16
Mass Azithromycin Distribution to Prevent Child Mortality in Burkina Faso: The CHAT Randomized Clinical Trial.
在布基納法索進行的質輔酸胺分發以預防兒童死亡:CHAT隨機臨床試驗。
JAMA 2024-02-22
Optimised prevention of postnatal HIV transmission in Zambia and Burkina Faso (PROMISE-EPI): a phase 3, open-label, randomised controlled trial.
優化贊比亞和布基納法索的新生兒後天HIV傳播預防(PROMISE-EPI):第3期、開放標籤、隨機對照試驗。
Lancet 2024-03-14
Feasibility, safety, and impact of the RTS,S/AS01<sub>E</sub> malaria vaccine when implemented through national immunisation programmes: evaluation of cluster-randomised introduction of the vaccine in Ghana, Kenya, and Malawi.
在國家免疫計畫中實施 RTS,S/AS01<sub>E</sub> 疟疾疫苗的可行性、安全性和影響:對加納、肯亞和馬拉威引入該疫苗的集群隨機評估。
Lancet 2024-04-07
Burden of bacterial antimicrobial resistance in low-income and middle-income countries avertible by existing interventions: an evidence review and modelling analysis.
低收入和中等收入國家中珙菌抗藥性的負擔可通過現有干預措施避免:證據回顧和建模分析。
Lancet 2024-05-26